BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen C, Zheng H, Luo Y, Kong Y, An M, Li Y, He W, Gao B, Zhao Y, Huang H, Huang J, Lin T. SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer. J Clin Invest 2021;131:146431. [PMID: 33661764 DOI: 10.1172/JCI146431] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lu Y, Wang X, Gu Q, Wang J, Sui Y, Wu J, Feng J. Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets. Cell Death Discov 2022;8:337. [PMID: 35879279 DOI: 10.1038/s41420-022-01129-8] [Reference Citation Analysis]
2 Xia QD, Sun JX, Xun Y, Xiao J, Liu CQ, Xu JZ, An Y, Xu MY, Liu Z, Wang SG, Hu J. SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer. Front Immunol 2022;13:864156. [PMID: 35418978 DOI: 10.3389/fimmu.2022.864156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Wang Y, Zhang S, Bai Y, Li G, Wang S, Chen J, Liu X, Yin H. Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma. Front Cell Dev Biol 2022;10:809747. [PMID: 35309945 DOI: 10.3389/fcell.2022.809747] [Reference Citation Analysis]
4 Li CY, Brown S, Mehrara BJ, Kataru RP. Lymphatics in Tumor Progression and Immunomodulation. Int J Mol Sci 2022;23:2127. [PMID: 35216243 DOI: 10.3390/ijms23042127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Liu M, Yang J, Xu B, Zhang X. Tumor metastasis: Mechanistic insights and therapeutic interventions. MedComm (2020) 2021;2:587-617. [PMID: 34977870 DOI: 10.1002/mco2.100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhu Y, Li B, Xu G, Han C, Xing G. lncRNA MIR4435‑2HG promotes the progression of liver cancer by upregulating B3GNT5 expression. Mol Med Rep 2022;25:38. [PMID: 34859256 DOI: 10.3892/mmr.2021.12554] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Corrado C, Barreca MM, Zichittella C, Alessandro R, Conigliaro A. Molecular Mediators of RNA Loading into Extracellular Vesicles. Cells 2021;10:3355. [PMID: 34943863 DOI: 10.3390/cells10123355] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
8 Shi Y, Liu JB, Deng J, Zou DZ, Wu JJ, Cao YH, Yin J, Ma YS, Da F, Li W. The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma. Hereditas 2021;158:44. [PMID: 34758879 DOI: 10.1186/s41065-021-00208-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Su Q, Wu H, Zhang Z, Lu C, Zhang L, Zuo L. Exosome-Derived Long Non-Coding RNAs as Non-Invasive Biomarkers of Bladder Cancer. Front Oncol 2021;11:719863. [PMID: 34490118 DOI: 10.3389/fonc.2021.719863] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Zheng H, Chen C, Luo Y, Yu M, He W, An M, Gao B, Kong Y, Ya Y, Lin Y, Li Y, Xie K, Huang J, Lin T. Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer. Clin Transl Med 2021;11:e497. [PMID: 34323412 DOI: 10.1002/ctm2.497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]